Advanced search
Publication Cover
Future Oncology Volume 20, 2024 - Issue 16: Future Oncology
Submit an article Journal homepage
2,340
Views
0
CrossRef citations to date
0
Altmetric
Clinical Trial Protocol

The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions

Dong-Wan Kim1 Department of Internal Medicine, Seoul National University College of Medicine & Seoul National University Hospital, Seoul, 03080, Republic of KoreaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5124-7132View further author information
ORCID Icon,
Alison M Schram2 Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USAView further author information
,
Antoine Hollebecque3 Drug Development (DITEP), GI Oncology, Gustave Roussy Cancer Campus, Villejuif, 94805, FranceView further author information
,
Kazumi Nishino4 Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, 540-0008, JapanView further author information
,
Teresa Macarulla5 Gastrointestinal and Endocrine Tumor Unit, Vall d´Hebrón University Hospital, Vall d´Hebrón Institute of Oncology (VHIO), Barcelona, 08035, SpainView further author information
,
Sun Young Rha6 Department of Internal Medicine, Yonsei Cancer Center, Yonsei University Health System, Seoul, 03722, Republic of KoreaView further author information
,
Michaël Duruisseaux7 Department of Respiratory Medicine and Early Phase, Louis Pradel Hospital, Hospices Civils de Lyon Cancer Institute, Lyon, 69500, France;8 Cancer Research Centre of Lyon, UMR INSERM 1052 CNRS 5286, Lyon, 69008, France;9 Claude Bernard University Lyon 1, University of Lyon, Villeurbanne, 69100, FranceView further author information
,
Stephen V Liu10 Thoracic Oncology and Developmental Therapeutics, Lombardi Comprehensive Cancer Center, Georgetown University, WA 20007, USAView further author information
,
Mohammed Najeeb Al Hallak11 Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USAView further author information
,
Kumiko Umemoto12 Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, 216-8511, JapanView further author information
,
Claas Wesseler13 Department of Pulmonology, Asklepios Tumorzentrum Hamburg, Klinikum Harburg, Hamburg, 21075, GermanyView further author information
,
James M Cleary14 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA;15 Harvard Medical School, Boston, MA 02215, USAView further author information
,
Christoph Springfeld16 Department of Medical Oncology, Heidelberg University Hospital, Department of Medical Oncology, Heidelberg, 69120, GermanyView further author information
,
Cindy Neuzillet17 GI Oncology, Medical Oncology Department, Curie Institute, Versailles-Saint Quentin University, Saint-Cloud, 92064, FranceView further author information
,
Andrew Joe18 Clinical Development, Merus NV, Utrecht, 3584, The NetherlandsView further author information
,
Shekeab Jauhari18 Clinical Development, Merus NV, Utrecht, 3584, The NetherlandsView further author information
,
Jim Ford19 Clinical Trials, Merus NV, Utrecht, 3584, The NetherlandsView further author information
&
Koichi Goto20 Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, 277-8577, JapanView further author information
 show all
Pages 1057-1067 | Received 22 Sep 2023, Accepted 04 Jan 2024, Published online: 13 Feb 2024

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.